TIRIBELLI, CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 32.375
AS - Asia 13.666
EU - Europa 13.634
SA - Sud America 1.802
AF - Africa 406
OC - Oceania 63
Continente sconosciuto - Info sul continente non disponibili 34
Totale 61.980
Nazione #
US - Stati Uniti d'America 31.943
SG - Singapore 5.227
PL - Polonia 3.315
CN - Cina 2.826
UA - Ucraina 1.867
IT - Italia 1.799
HK - Hong Kong 1.470
SE - Svezia 1.467
VN - Vietnam 1.431
BR - Brasile 1.405
DE - Germania 988
KR - Corea 757
FR - Francia 747
FI - Finlandia 697
TR - Turchia 636
GB - Regno Unito 573
RU - Federazione Russa 526
IE - Irlanda 408
BG - Bulgaria 390
IN - India 367
NL - Olanda 264
CA - Canada 256
AR - Argentina 148
JP - Giappone 112
BD - Bangladesh 111
MX - Messico 106
MA - Marocco 104
BE - Belgio 92
IQ - Iraq 91
ZA - Sudafrica 84
CH - Svizzera 80
PK - Pakistan 79
ID - Indonesia 76
SN - Senegal 71
ES - Italia 64
AT - Austria 59
IR - Iran 59
AU - Australia 54
DK - Danimarca 52
PH - Filippine 48
EC - Ecuador 47
VE - Venezuela 47
CL - Cile 46
SA - Arabia Saudita 44
CO - Colombia 37
EE - Estonia 34
CZ - Repubblica Ceca 33
TH - Thailandia 32
EG - Egitto 29
KE - Kenya 27
UZ - Uzbekistan 27
IL - Israele 25
JO - Giordania 25
LT - Lituania 25
PY - Paraguay 25
RO - Romania 25
DZ - Algeria 24
EU - Europa 24
MY - Malesia 24
TW - Taiwan 24
AE - Emirati Arabi Uniti 20
AZ - Azerbaigian 20
GR - Grecia 18
KZ - Kazakistan 18
PE - Perù 18
PT - Portogallo 15
RS - Serbia 15
TN - Tunisia 15
NP - Nepal 14
BO - Bolivia 13
LB - Libano 13
OM - Oman 13
UY - Uruguay 12
AL - Albania 11
KG - Kirghizistan 11
NG - Nigeria 11
DO - Repubblica Dominicana 9
GE - Georgia 9
HR - Croazia 9
MD - Moldavia 9
PA - Panama 9
AM - Armenia 8
CR - Costa Rica 8
ET - Etiopia 8
HU - Ungheria 8
JM - Giamaica 8
LK - Sri Lanka 8
NO - Norvegia 8
NZ - Nuova Zelanda 8
SI - Slovenia 8
SK - Slovacchia (Repubblica Slovacca) 8
A2 - ???statistics.table.value.countryCode.A2??? 7
HN - Honduras 7
PS - Palestinian Territory 7
NI - Nicaragua 6
GA - Gabon 5
GH - Ghana 5
GT - Guatemala 5
LA - Repubblica Popolare Democratica del Laos 5
LV - Lettonia 5
Totale 61.887
Città #
Woodbridge 3.267
Singapore 3.215
Fairfield 3.146
Warsaw 2.942
Ashburn 2.792
Ann Arbor 2.730
Houston 2.533
Chandler 2.170
Jacksonville 1.647
Wilmington 1.552
Hong Kong 1.439
Seattle 1.357
San Jose 1.265
Cambridge 1.058
Seoul 714
Princeton 703
Hefei 640
Boardman 600
Beijing 592
Trieste 537
Izmir 512
Chicago 471
Ho Chi Minh City 437
Dublin 397
Sofia 385
Columbus 362
Zgierz 347
Lauterbourg 346
Hanoi 314
Los Angeles 303
Moscow 234
Dallas 229
The Dalles 225
Santa Clara 221
Frankfurt am Main 190
San Diego 184
Buffalo 178
New York 168
Dearborn 158
Falls Church 158
Milan 152
Helsinki 149
Council Bluffs 143
London 141
Munich 139
São Paulo 131
Toronto 129
Des Moines 122
Düsseldorf 120
Brussels 85
Tokyo 85
Shanghai 76
Casablanca 73
Phoenix 73
Dakar 71
Amsterdam 70
Guangzhou 64
Orem 64
Redondo Beach 64
Dong Ket 56
Washington 56
Redwood City 55
Da Nang 54
Montreal 54
Nuremberg 54
Norwalk 53
Turku 53
Haiphong 52
Denver 51
Kocaeli 51
Atlanta 50
Mumbai 49
Bremen 48
Rio de Janeiro 48
Rome 48
Brooklyn 46
Copenhagen 45
Johannesburg 45
Bern 44
Verona 42
San Francisco 41
Kunming 40
Vienna 40
Chennai 35
Jinan 34
Nanjing 34
Stockholm 34
Tallinn 34
Boston 32
Belo Horizonte 30
Krefeld 30
Baghdad 29
Dhaka 28
Redmond 28
Indiana 27
Brasília 26
Curitiba 26
Manchester 26
Amman 25
Mexico City 25
Totale 44.347
Nome #
Bilirubin and inflammation in neurodegenerative and other neurological diseases 626
Brain Cytochrome p450 enzymes: a possible Therapeutic Targets for Neurological Diseases 449
The role of multipotent cancer associated fibroblasts in hepatocarcinogenesis 432
The biological effects of bilirubin photoisomers 427
An animal model for the juvenile non-alcoholic fatty liver disease and non-alcoholic steatohepatitis 422
Evaluation of region selective bilirubin-induced brain damage as a basis for a pharmacological treatment 412
Transcriptional Up-Regulation of APE1/Ref-1 in hepatic tumor: Role in hepatocytes resistance to oxidative stress and apoptosis 405
Effects of oral administration of silymarin in a juvenile murine model of non-alcoholic steatohepatitis 399
MicroRNAs as Regulators of Neo-Angiogenesis in Hepatocellular Carcinoma 398
Silencing efficacy prediction: a retrospective study on target mRNA features 384
Hepatitis C-related cryoglobulinemic neuropathy: Potential role of oxcarbazepine for pain control 380
Serum Stem Cell Growth Factor Beta for the Prediction of Therapy Response in Hepatocellular Carcinoma 380
Histone acetylation as a new mechanism for bilirubin-induced encephalopathy in the Gunn rat 353
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 350
Serum AP-endonuclease 1 (sAPE1) as novel biomarker for hepatocellular carcinoma 348
Neuro-inflammatory effects of photodegradative products of bilirubin 340
Earliest mechanisms of dopaminergic neurons sufferance in a novel slow progressing ex vivo model of parkinson disease in rat organotypic cultures of substantia nigra 323
null 312
Anti-transglutaminase antibodies and age. 297
A new insight on the stem cell growth factor beta as astrong predictor of therapy response in hepatocellular carcinoma 297
Management of restless legs syndrome in chronic liver disease: a challenge for the correct diagnosis and therapy 289
Thiamine and alcohol for brain pathology: super-imposing or different causative factors for brain damage? 280
Modulation of Mrp1 (ABCc1) and Pgp (ABCb1) by bilirubin at the blood-CSF and blood-brain barriers in the Gunn rat. 278
Abnormal apolipoprotein B pre-mRNA splicing in patients with familial hypobetalipoproteinaemia 270
Accuracy of body mass index in detecting an elevated alanine aminotransferase level in adolescents. 270
Rescue of bilirubin-induced neonatal lethality in a mouse model of Crigler-Najjar syndrome type I by AAV9-mediated gene transfer. 269
A proteomic approach to the bilirubin-induced toxicity in neuronal cells reveals a protective function of DJ-1 protein. 266
Podocyte expression of membrane transporters involved in puromycin aminonucleoside-mediated injury. 263
A simple index of lipid overaccumulation is a good marker of liver steatosis. 259
Identification and evaluation of novel non-invasive biomarkers for non-alcoholic fatty liver disease 252
Heterologous ferredoxin reductase and flavodoxin protect Cos-7 cells from oxidative stress. 251
Overoxidation of peroxiredoxins as an immediate and sensitive marker of oxidative stress in HepG2 cells and its application to the redox effects induced by ischemia/reperfusion in human liver. 250
HBV, HCV, and TTV detection by in situ polymerase chain reaction could reveal occult infection in hepatocellular carcinoma: comparison with blood markers 249
Rapid method for detection of extra (TA) in the promoter of Bilirubin-UDP-Glucuronosyl transferase 1 gene associated with Gilbert Syndrome 249
NOVEL BIOMARKERS FOR THE DIAGNOSIS OF LIVER FIBROSIS IN A HIGHLY RISK NAFLD COHORT in IFSO 2017 22(nd) World Congress 246
1H-NMR Spectroscopic Studies of Lipid Extracts from Human Fatty Liver 245
Alterations in the cell cycle in the cerebellum of hyperbilirubinemic gunn rat: a possible link with apoptosis? 241
Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma. 240
Alcohol-induced liver disease: From molecular damage to treatment. 240
TACE with cone beam computed tomography is more effective than traditional technique in BCLC A HCC patients ineligible to surgery 237
The Many Functions of APE1/Ref-1: Not Only a DNA Repair Enzyme 236
Modern strategies to identify new molecular targets for the treatment of liver diseases: The promising role of Proteomics and Redox Proteomics investigations 235
Binding of tritiated bilirubin to albumin and plasma membrane vesicles: a reply 233
The role of ABC transporters in protecting cells from bilirubin toxicity 233
Homocysteine in neurology: From endothelium to Neurodegeneration 232
The cytotoxic effect of unconjugated bilirubin in human neuroblastoma SH-SY5Y cells is modulated by the expression level of MRP1 but not MDR1 231
Blood flow changes in hepatocellular carcinomas after the administration of Thaliodomide by reperfusion kinetics during microbubble infusion: Preliminary results. 229
Life-long correction of hyperbilirubinemia with a neonatal liver-specific AAV-mediated gene transfer in a lethal mouse model of Crigler-Najjar Syndrome. 228
Predictors of non-alcoholic fatty liver disease in obese children 227
Neonatal hyperbilirubinemia 225
A simple in silico strategy identifies candidate biomarkers for the diagnosis of liver fibrosis in morbidly obese subjects 225
Stem cells compartment activation during hepatocarcinogenesis in a HBV-transgenic mouse model 224
Albumin binding of 3H-unconjugated bilirubin and its uptake by rat liver basolateral plasma membrane vesicles 224
Alcohol, liver and genes: an intricate puzzle 224
Effect of tauroursodeoxycholic and ursodeoxycholic acid on ethanol-induced cell injuries in the human Hep G2 cell line 224
Liver bromosulphonphthalein transport as a carrier mediated process 223
Hepatic cancer stem cells and drug resistance: relevance in targeted therapies of hepatocellular carcinoma 222
Functional induction of the cystine-glutamate exchanger system Xc(-) activity in SH-SY5Y cells by unconjugated bilirubin. 221
Kinetics of the inflammatory response induced by free fatty acid accumulation in hepatocytes 221
Biochemical investigations in the management of liver disease 219
Liver and adipose tissue interplay through the up-regulation of the Th17 pathway 219
Repeated double cross-validation applied to the PCA-LDA classification of SERS spectra: a case study with serum samples from hepatocellular carcinoma patients 219
Anti-transglutaminase and age, Clinical Chemestry 217
Kinetics and specificity of feline leukemia virus subgroup C receptor (FLVCR) export function and its dependence on hemopexin. 216
The pros and the cons for the use of Silybin-rich oral formulations in treatment of liver damage (NAFLD in particular) 215
Role of brain Cytochrome P450 mono-oxygenases in bilirubin oxidation - specific induction and activity. 215
ATP-dependent transport of unconjugated bilirubin by rat liver canalicular plasma membrane vesicles 215
MiR-3201 as a Prognostic Blood Biomarker for Curative Treatments in Hepatocellular Carcinoma 214
Cancer stem cell markers analysis in a HBV-transgenic HCC mouse model 214
Bilitranslocase is the protein responsible for the electrogenic movement of sulfobromo-phthalein in plasma membrane vesiscles from rat liver: immuno chemical evidence using mono and poly clonal antibodies 214
A protective effect of breastfeeding on the progression of nonalcoholic fatty liver disease. 214
Multidrug resistance in hepatic cancer stem cells: the emerging role of miRNAs 213
Bilirubin inhibits the TNFα-related induction of three endothelial adhesion molecules 213
Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease. 212
Changing molecular epidemiology of hepatitis C virus infection in Northeast Italy. 211
Bilistick: A Low Cost Point-of-Care System to Measure Total Plasma Bilirubin 211
Specific Inhibition of the Redox Activity of Ape1/Ref-1 by E3330 Blocks Tnf-α-Induced Activation of Il-8 Production in Liver Cancer Cell Lines 210
A comparative characterization of the circulating miRNome in whole blood and serum of HCC patients 210
Alcohol and Nutrition as Risk Factors for Chronic Liver Disease 209
Bilirubin mediated oxidative stress involves antioxidant response activation via Nrf2 pathway. 208
Recent insights on hepatic cancer stem cells. 207
Reconstitution in vitro of sulfobromophthalein transport by bilitranslocase 207
Chronic administration of ursodeoxycholic and tauroursodeoxycholic acid changes microsomal membrane lipid content and fatty acid composition in rats 207
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis. 205
Body Mass Index is a good predictor of an elevated alanine transaminase level in the general population: Hints from the Dionysos study. 205
Looking to the horizon: The role of bilirubin in development and prevention of age-related chronic diseases 204
Transport of sulfobromophthalein and taurocholate in the HepG2 cell line in relation to the expression of membrane carrier proteins. 204
Cohort effect of HCV infection in liver cirrhosis assessed by a 25 years study 203
Oxidative Stress, Antioxidant Defenses, and the Liver. 203
A rational use of laboratory tests in the diagnosis and management of hepatitis C virus infection 203
The Next Generation Sequencing (NGS) platform in the assessment of the gut microbiota in bariatric surgery. 203
Body Mass Index: from Quételet to evidence-based medicine 202
The expression levels of the translational factors eEF1A 1/2 correlate with cell growth but not apoptosis in hepatocellular carcinoma cell lines with different differentiation grade 201
The importance of the interaction between hepatocyte and hepatic stellate cells in fibrogenesis induced by fatty accumulation. 201
The spectrum of liver disease in the general population: Lesson from the Dionysos study. 200
The plasticity of the stem cells in the hepatocarcinogenesis and metastasis: study in vitro and in vivo 198
Abnormal hepatic uptake of low doses of sulfobromophthalein in Gilbert's syndrome: the role of reduced affinity of the plasma membrane carrier of organic anions. 197
Differentiation between stages of non-alcoholic fatty liver diseases using surface-enhanced Raman spectroscopy 197
Bilirubin accumulation and Cyp mRNA expression in selected brain regions of jaundiced Gunn rat pups. 196
Effect of bilirubin on cytochrome c oxidase activity of mitochondria from mouse brain and liver. 196
Totale 25.722
Categoria #
all - tutte 182.350
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 182.350


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.341 0 0 0 0 0 0 0 0 0 583 206 552
2021/20224.029 158 305 278 363 112 349 194 179 514 448 282 847
2022/20235.960 513 562 361 838 686 1.143 59 569 756 52 312 109
2023/20243.242 244 219 165 209 357 360 450 645 54 89 227 223
2024/20257.179 100 217 422 693 703 762 615 452 936 877 620 782
2025/202615.869 1.754 887 1.156 1.298 1.659 1.805 2.656 641 2.128 1.885 0 0
Totale 63.083